Winners announced for Crayon High School Art Competition which honours young cancer warriors
Crayon, a specialist Paediatric, Adolescent, and Young Adult Oncology unit based in the Northern suburbs of the Cape Metropole, celebrated its official launch on Thursday, 16 November. The event was attended by members of the oncology community who are dedicated to delivering care to young people living with cancer.
Icon Oncology and Cancercare earlier this year collaborated to establish Crayon with a ‘dream team’ to help address the rising incidence of cancer in younger people. As the brainchild of Dr Johann Riedemann, the Crayon unit is based at Cape Gate Oncology Centre and focuses on solid tumour pathology which includes nervous system cancers, head and neck cancers, nasopharynx, lung cancers, abdominal cancers, soft tissue cancer and urogenital cancers.
Dr Riedemann says that a team of highly skilled individuals has come together to provide personalised care for every patient. “We have some of the most brilliant minds in their respective fields on our team and every patient case is discussed and carefully considered. The main goal is to ensure safe and effective treatment whilst also creating a system for ongoing care and survivorship to address any potential consequences of the disease process and associated therapy,” says Dr Riedemann.
As part of the celebration, the winners of the Crayon high school art competition, which was launched in September to commemorate Childhood Cancer Awareness Month, were also announced.
The competition, themed ‘Dreams and Wishes,’ invited learners from high schools in the Northern Suburbs of Cape Town to illustrate the dreams, hopes, and wishes of children affected by cancer. The aim was to shed light on the strength, bravery, and aspirations of these young cancer warriors, bringing attention to the importance of childhood cancer diagnosis, detection, and treatment.
Dr. Johann Riedemann, expressed excitement about the initiative, stating, “This competition allows us to pay tribute to the incredible strength and resilience of our young heroes.”
The competition received a wonderful response, with students showcasing their artistic talents while conveying powerful messages of hope and courage. The entries were judged based on creativity, adherence to the theme, and the emotional impact of the artwork.
After careful consideration, the judging panel is pleased to announce the following winners:
- First Place (Winning a R5000 Takealot voucher): Jana Elizabeth Burger, DF Malan
- Second Place (Winning R2500 Takealot voucher):Miguel Titus, Saxon Sea
- Third Place (Winning a R1750 Takealot voucher): Stephanie Anthonie, Emelia’s Art for All
Furthermore, 9 runners-up were selected with each one receiving a R300 Tygervalley Shopping Centre voucher. The artworks of the top 12 finalists will be turned into a 2024 printed calendar.
Dr Riedemann commended all participants, stating, “The level of creativity and thoughtfulness displayed by the learners is truly inspiring. We believe that art has the power to convey emotions and messages that words sometimes cannot.”
This art competition is part of Crayon’s ongoing efforts to raise awareness about childhood cancer and the importance of early detection. The winning artworks will be showcased at the Crayon unit allowing the community to appreciate the talent and dedication of these young artists.
An average of 800 to 1 000 children are newly diagnosed with cancer annually in South Africa and it’s estimated that at least half of all children with cancer in the country are never diagnosed.
For more information about Crayon and its initiatives, please visit www.cancercrayon.co.za.
Crayon is a specialist Paediatric, Adolescent, and Young Adult Oncology unit based in the Northern suburbs of the Cape Metropole. The unit is committed to delivering the best possible care and outcomes for young patients, with a focus on solid tumour pathology. Crayon stands for Childhood, Radiation, Adolescent, Young Adult, Oncology Network and is a collaboration between Icon Oncology and Cancercare.